Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced Neuroinflammation and Regulates MAPK and NF‐κB Pathways In Vitro and In Vivo
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: Background and purpose: Beta‐amyloid (A β)‐mediated inflammation contributes to the progression and chronicity of A lzheimer's disease (AD), although the exact mechanism remains unclear. This study aimed to investigate whether diammonium glycyrrhizinate (DG) could inhibit A β‐induced inflammation in vitro and in vivo and to explore the underlying mechanisms. Methods: Aβ 1–42 was injected to bilateral hippocampus of mice to make the AD models in vivo. The levels of m RNA and protein of inflammatory cytokines were measured by real‐time PCR and Western blotting, respectively. The viability of SH‐SY 5 Y and HT‐22 cells was determined by MTT. NF‐κ B p65 translocation was analyzed by W estern blotting and immunostaining. Phosphorylation of ERK, p38, and JNK was tested by Western blotting. Results: DG suppressed A β 1–42‐induced activation of microglia and inflammation in vitro and in vivo. The media from A β 1–42‐activated microglia decreased the viability of SH‐SY 5 Y and HT‐22 cells, but it was rescued when pretreated with DG. DG could inhibit the activation of MAPK and NF‐κ B signaling pathways and attenuate the memory deficits in A β 1–42‐induced AD mice. Conclusions: DG protects A β 1–42‐induced AD models in vitro and in vivo through reducing activation of microglia and inflammation, which may be involved in MAPK and NF‐κ B pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224
Cited by
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Kaur, D., Sharma, V., & Deshmukh, R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 484
Sun, J., & Nan, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2962 · Cited by 242
Srinivasan, M., & Lahiri, D. K. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.989834 · Cited by 164
“Diammonium glycyrrhizinate (Table 1), the salt form of GA, has been shown to inhibit Ab1--42-induced activation of p65 and MAPK signaling pathways in microglial cells and attenuate memory deficits in Ab1-42-induced AD in mice [78].”
BackgroundHDAC 3 negatively regulates spatial memory in a mouse model of Alzheimer's disease
Zhu, X., Wang, S., Yu, L., Jin, J., Ye, X., Liu, Y., & Xu, Y. (2017) · Aging Cell · doi:10.1111/acel.12642 · Cited by 112
“Qualitative immunostaining analyses were conducted as previously described (Zhao et al., 2013).”
MethodSelf-citationParaquat-induced inflammatory response of microglia through HSP60/TLR4 signaling
Sun, Y., Zheng, J., Xu, Y., & Zhang, X. (2018) · Human & Experimental Toxicology · doi:10.1177/0960327118758152 · Cited by 61
Self-citationZheng, Y., Zhang, X., Zhang, R., Wang, Z., Gan, J., Gao, Q., Yang, L., Xu, P., & Jiang, X. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5314 · Cited by 52
Metadata
- Authors
- Zhao, H., Wang, S., Qian, L., Jin, J., Li, H., Xu, Y., & Zhu, X.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2012-12-20
- Volume
- 19
- Issue
- 2
- Pages
- 117-124
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W1998784502
- Cited by
- 70
- References
- 3
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.